
1. Rev Soc Bras Med Trop. 2019 Feb 21;52:e20180225. doi:
10.1590/0037-8682-0225-2018.

Plasmodium falciparum malarial parasites from Brazil lack artemisinin
resistance-associated mutations in the kelch13 gene.

Chapadense F(1), Machado RLD(2)(3), Ventura AMRDS(3), Áreas A(4), Machado RB(1), 
Viana GR(3), Zalis MG(4), Castro AM(1), Cravo P(5)(6).

Author information: 
(1)Universidade Federal de Goiás, Instituto de Patologia Tropical e Saúde
Pública, Goiânia, GO, Brasil.
(2)Universidade Federal de Fluminense, Departamento de Microbiologia e
Parasitologia, Niterói, RJ, Brasil.
(3)Instituto Evandro Chagas, Ministério da Saúde, Setor de Parasitologia,
Ananindeua, PA, Brasil.
(4)Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino
Fraga Filho, Laboratório de Infectologia e Parasitologia Molecular, Rio de
Janeiro, RJ, Brasil.
(5)Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa,
Portugal.
(6)UniEvangélica, Centro Universitário de Anápolis, Anápolis, GO, Brasil.

INTRODUCTION: Mutations in the propeller domain of the Plasmodium falciparum
kelch13 (k13) gene are associated with artemisinin resistance.
METHODS: We developed a PCR protocol to sequence the pfk13 gene and determined
its sequence in a batch of 50 samples collected from 2003 to 2016 in Brazil.
RESULTS: We identified 1 K189T substitution located outside the propeller domain 
of the PfK13 protein in 36% of samples.
CONCLUSIONS: Although the sample size is relatively small, these results suggest 
that P. falciparum artemisinin-resistant mutants do not exist in Brazil, thereby 
supporting the continuation of current treatment programs based on
artemisinin-based combination therapy.

DOI: 10.1590/0037-8682-0225-2018 
PMID: 30810653  [Indexed for MEDLINE]

